Close Menu

NEW YORK (GenomeWeb) – Researchers led by a team at Yale University School of Medicine have found that two hereditary cancer syndromes result in the loss of a type of DNA repair that renders tumor cells vulnerable to poly(ADP)-ribose polymerase (PARP) inhibitors, suggesting a new treatment for patients with advanced disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.